YOLFTbeta
Beijing Bohui Innovation Technology Co Ltd

Beijing Bohui Innovation Technology Co Ltd

300318 · SHE · Healthcare / Biotechnology

4.42CNY-0.12 (-2.64%)

Price History

Full chart

Market Stats

Previous Close4.54
Open4.55
Day Range4.39 – 4.55
52-Week Range4.06 – 8.63
Volume6.69M
Market Cap4.27B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.11
Dividend Yield0.00%
Beta0.10
50-Day Avg4.98
200-Day Avg5.54

About

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of in-vitro diagnostic products in China and internationally. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; human serum albumin; human prothrombin complex and human coagulation factor VIII; and vaccine for rabies. It also provides molecular diagnostics platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay Analyzers, and Quantum Dot Analyzer; and detection kits for respiratory, intestinal, reproductive infections, as well as trace element testing, allergen testing, and others. In addition, the company offers mass spectrometers, plate readers, and standardized ion sources; and flash, process, and preparative purification systems. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhiwei Shen
  • Employees2.17K
  • HeadquartersNo. 9 Courtyard, Shengshengyuan Road, Beijing, China, 102206, China
  • Websitehttps://www.bohui-tech.com

Leadership

  • Mr. Zhiwei ShenChairman of the Board & GM · b. 1978
  • Ms. Jia LiuHead of Accounting Department, Financial Director & CFO · b. 1984
  • Mr. Haifeng DongDeputy GM, Secretary & Director · b. 1984

Financials

Income Statement

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue24.51M25.88M29.37M39.40M51.46M63.58M78.41M98.12M113.76M106.87M100.97M268.85M404.05M443.75M622.09M628.34M738.72M714.75M795.93M1.05B851.69M824.58M
Growth (%)-+5.57%+13.49%+34.16%+30.62%+23.55%+23.31%+25.14%+15.94%-6.06%-5.52%+166.26%+50.29%+9.83%+40.19%+1.00%+17.57%-3.24%+11.36%+31.35%-18.53%-3.18%
Cost of Revenue5.31M5.92M6.19M9.73M11.95M14.55M16.62M22.63M25.41M24.12M21.63M140.78M189.69M209.44M310.03M324.40M385.56M422.28M542.42M593.97M434.16M498.40M
Gross Profit19.20M19.96M23.17M29.67M39.51M49.04M61.79M75.49M88.35M82.75M79.33M128.07M214.36M234.31M312.07M303.94M353.16M292.47M253.51M451.46M417.53M326.17M
Gross Margin78.35%77.12%78.91%75.30%76.78%77.12%78.80%76.94%77.66%77.43%78.57%47.64%53.05%52.80%50.16%48.37%47.81%40.92%31.85%43.18%49.02%39.56%
Operating Expense7.10M6.60M10.56M6.73M-4.73M20.55M24.72M25.99M32.62M37.99M39.99M117.20M170.73M134.72M204.43M292.86M349.70M794.77M381.14M417.65M382.35M319.22M
Operating Income12.10M13.36M12.61M22.93M44.24M28.49M37.06M49.50M55.73M44.76M39.34M10.87M43.63M99.59M107.63M11.08M3.46M-502.31M-127.63M33.81M35.18M6.95M
Operating Margin49.38%51.63%42.95%58.21%85.96%44.81%47.27%50.45%48.99%41.88%38.96%4.04%10.80%22.44%17.30%1.76%0.47%-70.28%-16.04%3.23%4.13%0.84%
EBITDA11.27M12.10M13.82M19.32M22.28M30.13M39.42M56.92M57.98M80.93M57.62M44.12M96.10M176.37M208.98M126.33M127.15M-353.42M15.12M161.12M142.89M-38.46M
EBITDA Margin45.99%46.76%47.06%49.05%43.29%47.39%50.28%58.01%50.96%75.73%57.06%16.41%23.78%39.75%33.59%20.11%17.21%-49.45%1.90%15.41%16.78%-4.66%
Net Income13.79M13.92M12.95M22.30M39.85M25.91M33.74M44.78M50.95M54.26M38.14M11.88M23.60M38.85M69.44M2.54M7.50M-322.18M-78.44M-24.93M9.25M-91.92M
Net Income Margin56.26%53.79%44.11%56.60%77.44%40.75%43.04%45.63%44.79%50.77%37.77%4.42%5.84%8.76%11.16%0.40%1.02%-45.08%-9.86%-2.38%1.09%-11.15%
R&D-----5.22M7.21M8.33M11.24M11.89M22.31M35.52M40.54M48.51M53.46M46.58M48.18M81.48M64.78M69.20M52.52M64.92M
R&D as % of Total Revenue-----8.21%9.19%8.49%9.88%11.12%22.09%13.21%10.03%10.93%8.59%7.41%6.52%11.40%8.14%6.62%6.17%7.87%
Interest Expense-172.13K548.23K-88.47K11019.82K27.15K22.05K13.11M6.66M180.16K7.62M27.09M34.45M43.76M36.64M45.88M43.21M28.67M29.83M33.43M
Interest Expense % of Total Revenue-0.67%1.87%-0.17%0.00%0.03%0.03%0.02%12.27%6.59%0.07%1.89%6.10%5.54%6.96%4.96%6.42%5.43%2.74%3.50%4.05%

Balance Sheet

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets57.70M76.12M80.53M106.00M145.40M177.90M214.68M261.70M701.23M752.40M799.34M2.07B2.09B2.74B2.71B2.69B3.72B3.69B3.91B3.93B4.13B4.30B
Total Liabilities8.38M12.38M3.58M6.75M9.44M8.28M8.68M12.18M42.25M49.84M72.77M786.91M569.86M1.12B1.47B1.64B2.28B2.76B1.58B1.59B1.78B2.13B
Total Equity49.32M63.74M76.95M99.25M134.66M161.49M196.70M241.47M652.44M697.46M724.13M1.39B1.42B1.47B1.17B1.03B1.30B974.75M1.39B1.37B1.38B1.29B
Cash34.24M14.15M31.07M4.39M70.30M65.39M78.06M113.61M456.58M459.97M429.47M111.33M46.08M67.28M102.51M30.06M44.60M39.39M113.60M104.93M77.26M121.83M
Total Debt5.00M10.00M---------24.21M45.38M278.82M331.89M611.87M616.27M554.64M789.33M745.92M880.05M-
Net Debt-29.24M-4.15M-31.07M-4.39M-70.30M-65.39M-78.06M-113.61M-456.58M-459.97M-429.47M-87.12M-693.20K211.54M229.38M581.81M571.68M515.24M675.73M641.00M802.79M719.68M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.40M23.30M16.04M22.79M32.23M46.89M61.28M55.08M31.05M88.95M77.97M-95.19M-84.15M-36.03M86.14M887.78K40.72M137.02M-38.69M-135.17M
Investing Cash Flow17.68M-49.97M57.05M-29.87M-22.47M-10.64M-79.20M-41.36M-150.52M-226.08M-106.32M-110.59M-47.66M-130.87M-361.05M-379.01M-139.77M-169.27M-186.60M-
Financing Cash Flow-10.16M2.50M-7.56M2.17M2.97M-663.53K360.88M-10.33M-11.50M-81.42M-37.21M227.87M166.90M94.06M288.77M369.64M172.60M8.25M198.31M-
Capital Expenditure25.10M1.08M24.89M29.87M22.47M10.88M79.22M41.36M59.43M35.09M37.40M39.55M53.29M108.87M202.33M367.06M161.46M197.54M188.95M156.92M
Free Cash Flow-15.70M22.22M-8.85M-7.09M9.76M36.01M-17.94M13.72M-28.38M53.86M40.57M-134.75M-137.44M-144.90M-116.20M-366.17M-120.74M-60.53M-227.64M-292.09M
Dividends Paid470.19K-7.84M----10.24M11.47M4.16M2.93M12.52M16.75M29.49M27.27M25.95M26.75M51.15M32.66M31.38M
FCF to OCF-167.03%95.37%-55.17%-31.10%30.29%76.80%-29.27%24.91%-91.39%60.55%52.04%141.55%163.33%402.19%-134.90%-41245.77%-296.52%-44.18%588.36%216.10%
Dividend Paid to FCF-2.99%--88.54%----74.63%-40.42%7.73%7.23%-9.29%-12.19%-20.35%-23.47%-7.09%-22.16%-84.50%-14.35%-10.74%

Earnings

Report DateJun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 19, 2014Oct 20, 2014Feb 17, 2015Apr 23, 2015Aug 24, 2015Oct 23, 2015Feb 19, 2016Apr 29, 2016Aug 22, 2016Oct 24, 2016Feb 28, 2017Apr 20, 2017Aug 21, 2017Oct 19, 2017Feb 2, 2018Apr 26, 2018Aug 13, 2018Oct 22, 2018Dec 31, 2018Apr 22, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 27, 2020Aug 28, 2020Oct 27, 2020Dec 31, 2020Apr 27, 2021Aug 27, 2021Oct 28, 2021Dec 31, 2021Apr 28, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 17, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------------------------------
EPS Actual0.040.030.010.010.020.030.020.010.020.020.010.010.030.01-0.020.000.010.010.000.000.020.010.020.010.010.010.06-0.010.010.00-0.00-0.02-0.000.030.00-0.01-0.01-0.01-0.36-0.02-0.01-0.02-0.050.010.000.01-0.050.020.01-0.00-0.02-0.01-0.02-0.02-0.07-0.01-0.01
Surprise---------------------------------------------------------
Timing--------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-Pre-market-----------Pre-market-------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.27B
Enterprise Value5.08B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales5.23
Price / Book3.36
EPS-0.11
Book Value1.56
Revenue (TTM)816.14M
Gross Profit (TTM)260.28M
EBITDA32.22M
Profit Margin-10.89%
Operating Margin-9.77%
Return on Equity-7.65%
Return on Assets-0.81%
Shares Outstanding816.90M
Shares Float317.69M
Beta0.10
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
0.01Jul 12, 2018
20171×
0.00Jul 12, 2017
20161×
0.00Jun 21, 2016
20151×
0.01Jul 21, 2015
20141×
0.02Jul 16, 2014
20131×
0.02Jun 3, 2013

Stock Splits

  • Jun 21, 201619.9207:10
  • Jul 21, 201520:10
  • Jun 3, 201316:10